Compound ID | 1928
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Cell wall synthesis inhibitor. Binds to bacterial penicillin-binding proteins (PBP); PBP inhibitor |
| Target Pathogen: | Active against Gram-positive bacteria, especially staphylococci including penicillinase producing strains |
| Description: | Semisynthetic penicillin, derived from 6-aminopenicillanic acid (6-APA); parenteral application; an isoxazolylpenicillin-type |
| Year first mentioned: | 1963 |
| Highest development stage: | Approved by FDA in 1971 |
| Development status: | Approved |
| Reason dropped: | Discontinued/Withdrawn in many countries |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/6098 |
| Guide to Pharmacology: | cloxacillin |
| Citations: |
|